Soo‐Ok Kim

1.1k total citations
29 papers, 925 citations indexed

About

Soo‐Ok Kim is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Soo‐Ok Kim has authored 29 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 13 papers in Infectious Diseases and 13 papers in Hepatology. Recurrent topics in Soo‐Ok Kim's work include Hepatitis B Virus Studies (16 papers), Hepatitis C virus research (13 papers) and Liver Disease Diagnosis and Treatment (7 papers). Soo‐Ok Kim is often cited by papers focused on Hepatitis B Virus Studies (16 papers), Hepatitis C virus research (13 papers) and Liver Disease Diagnosis and Treatment (7 papers). Soo‐Ok Kim collaborates with scholars based in South Korea and United States. Soo‐Ok Kim's co-authors include Wangdon Yoo, Sun Pyo Hong, Kang Mo Kim, Dong Jin Suh, Young‐Suk Lim, Han Chu Lee, Young‐Hwa Chung, Yoon‐Seon Lee, Yung Sang Lee and Hyun Jae Chung and has published in prestigious journals such as Gastroenterology, Hepatology and Nature Protocols.

In The Last Decade

Soo‐Ok Kim

29 papers receiving 883 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Soo‐Ok Kim South Korea 13 649 530 229 146 87 29 925
Maja Kodani United States 14 296 0.5× 95 0.2× 206 0.9× 174 1.2× 45 0.5× 24 675
Seishi Asari Japan 18 347 0.5× 181 0.3× 182 0.8× 130 0.9× 104 1.2× 56 890
C. Magni Italy 14 434 0.7× 78 0.1× 331 1.4× 27 0.2× 224 2.6× 24 742
Tomoko Kiyohara Japan 17 448 0.7× 569 1.1× 233 1.0× 124 0.8× 25 0.3× 35 837
Mary L. Morris United States 9 308 0.5× 97 0.2× 124 0.5× 227 1.6× 41 0.5× 15 860
Norbert De Clercq Belgium 12 156 0.2× 183 0.3× 130 0.6× 101 0.7× 171 2.0× 18 545
Françoise Weber France 15 537 0.8× 79 0.1× 128 0.6× 131 0.9× 23 0.3× 17 867
Virginia Takahashi United States 11 185 0.3× 91 0.2× 132 0.6× 147 1.0× 64 0.7× 15 503
Volkmar Schottstedt Germany 16 237 0.4× 154 0.3× 219 1.0× 94 0.6× 52 0.6× 29 654
F. Caprilli Italy 16 488 0.8× 95 0.2× 180 0.8× 43 0.3× 9 0.1× 39 722

Countries citing papers authored by Soo‐Ok Kim

Since Specialization
Citations

This map shows the geographic impact of Soo‐Ok Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soo‐Ok Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soo‐Ok Kim more than expected).

Fields of papers citing papers by Soo‐Ok Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soo‐Ok Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soo‐Ok Kim. The network helps show where Soo‐Ok Kim may publish in the future.

Co-authorship network of co-authors of Soo‐Ok Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Soo‐Ok Kim. A scholar is included among the top collaborators of Soo‐Ok Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soo‐Ok Kim. Soo‐Ok Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Jae‐Hyun, et al.. (2024). Chimeric adenovirus-based herpes zoster vaccine with the tPA signal peptide elicits a robust T-cell immune response. Virology. 600. 110243–110243. 3 indexed citations
2.
Oh, Hyunseok, et al.. (2021). A purified inactivated vaccine derived from Vero cell-adapted zika virus elicits protection in mice. Virology. 560. 124–130. 6 indexed citations
3.
4.
Kim, Soo‐Ok, et al.. (2014). Effects of probiotics for the treatment of atopic dermatitis: a meta-analysis of randomized controlled trials. Annals of Allergy Asthma & Immunology. 113(2). 217–226. 115 indexed citations
5.
Min, Kyung Tae, et al.. (2014). Performance Evaluation of the TheraTyper-GJB2 Assay for Detection of GJB2 Gene Mutations. Journal of Molecular Diagnostics. 16(5). 573–583. 4 indexed citations
6.
Kim, Soon Sun, Sung Won Cho, Soo‐Ok Kim, Sun Pyo Hong, & Jae Youn Cheong. (2012). Multidrug‐resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: Clonal evolution during lamivudine plus adefovir therapy. Journal of Medical Virology. 85(1). 55–64. 19 indexed citations
7.
Jang, Jeong Won, et al.. (2011). Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma. Cancer Science. 103(2). 296–304. 36 indexed citations
8.
Lee, Hyo‐Pyo, Soo‐Ok Kim, Tae Sook Hwang, et al.. (2011). Analytical and clinical performances of a restriction fragment mass polymorphism assay for detection and genotyping of a wide spectrum of human papillomaviruses. Journal of Medical Virology. 83(3). 471–482. 9 indexed citations
9.
Kim, Soon Sun, Jae Youn Cheong, Myoung-Hee Lee, et al.. (2011). Adefovir‐based combination therapy with entecavir or lamivudine for patients with entecavir‐refractory chronic hepatitis B. Journal of Medical Virology. 84(1). 18–25. 12 indexed citations
10.
Cheong, Jae Youn, et al.. (2009). Association of lamivudine‐resistant mutational patterns with the antiviral effect of adefovir in patients with chronic hepatitis B. Journal of Medical Virology. 81(3). 417–424. 16 indexed citations
11.
Hong, Sun Pyo, Eun Hee Lee, Eun Ok Kim, et al.. (2008). High-resolution human papillomavirus genotyping by MALDI-TOF mass spectrometry. Nature Protocols. 3(9). 1476–1484. 31 indexed citations
12.
Cheong, Jae Youn, et al.. (2008). Emergence of adefovir‐resistant mutants after reversion to YMDD wild‐type in lamivudine‐resistant patients receiving adefovir monotherapy. Journal of Gastroenterology and Hepatology. 24(1). 49–54. 12 indexed citations
13.
Cheong, Jae Youn, Sung Won Cho, Jun Hwan Yoo, et al.. (2008). Selection of precore mutants during lamivudine treatment in patients with chronic hepatitis B.. PubMed. 55(84). 1029–33. 2 indexed citations
14.
Cheong, Jae Youn, Jin‐Sun Park, Myoung-Hee Lee, et al.. (2008). Factors affecting initial virologic response and emergence of resistant mutants after adefovir treatment in lamivudine-resistant chronic hepatitis B patients. The Korean Journal of Hepatology. 14(1). 58–58. 1 indexed citations
15.
Lee, Chang Hong, Soo‐Ok Kim, Kwan Soo Byun, et al.. (2006). Predominance of Hepatitis B Virus YMDD Mutants Is Prognostic of Viral DNA Breakthrough. Gastroenterology. 130(4). 1144–1152. 42 indexed citations
16.
Lee, Yoon‐Seon, Dong Jin Suh, Young‐Suk Lim, et al.. (2006). Increased risk of adefovir resistance in patients with lamivudine‐resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy†. Hepatology. 43(6). 1385–1391. 261 indexed citations
17.
Hong, Sun Pyo, Nam Keun Kim, Seong Gyu Hwang, et al.. (2004). Detection of hepatitis B virus YMDD variants using mass spectrometric analysis of oligonucleotide fragments. Journal of Hepatology. 40(5). 837–844. 116 indexed citations
18.
Hong, Sun Pyo, Wangdon Yoo, Robert Putnak, et al.. (2001). Nucleotide Sequence of Envelope Protein of Japanese Encephalitis Virus SA14-14-2 Adapted to Vero Cells. DNA sequence. 12(5-6). 437–442. 5 indexed citations
19.
Srivastava, Ashok K., J. Robert Putnak, Sun Pyo Hong, et al.. (2001). A purified inactivated Japanese encephalitis virus vaccine made in vero cells. Vaccine. 19(31). 4557–4565. 79 indexed citations
20.
Lee, Sung‐Hee, et al.. (1997). Nucleotide Sequence of Nucleocapsid Protein (N) of Hantaan Virus Isolated from a Korean Hemorrhagic Fever Patient. DNA sequence. 7(6). 349–352. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maja Kodani Breakdown of academic impact, for papers by Seishi Asari Breakdown of academic impact, for papers by C. Magni Breakdown of academic impact, for papers by Tomoko Kiyohara Breakdown of academic impact, for papers by Mary L. Morris Breakdown of academic impact, for papers by Norbert De Clercq Breakdown of academic impact, for papers by Françoise Weber Breakdown of academic impact, for papers by Virginia Takahashi Breakdown of academic impact, for papers by Volkmar Schottstedt Breakdown of academic impact, for papers by F. Caprilli
Rankless by CCL
2026